T1	Participants 91 120	advanced urothelial carcinoma
T2	Participants 326 421	patients with T3b, T4 or metastatic urothelial carcinoma treated with MEC or M-VAC chemotherapy
T3	Participants 490 568	From 1991 to 1995, 89 patients with T3b, T4 or metastatic urothelial carcinoma
T4	Participants 233 274	Japanese Urothelial Cancer Research Group
